Hyderabad advanced medical research hub gains boost with ₹1,200 crore biologics facility
Hyderabad: Information Technology and Industries Minister D. Sridhar Babu said the Telangana government was taking steps to position Hyderabad as a major hub for advanced medical research, including biologics, vaccines, cell and gene therapies, and treatments for cancer and rare diseases.
The Minister made the remarks after inaugurating the ₹1,200-crore Theranym Biologics manufacturing facility at Borpatla village in Hatnoora mandal of Sangareddy district on Wednesday.
Sridhar Babu said officials were preparing a comprehensive roadmap to create a world-class ecosystem covering the entire value chain, from research and development to commercial-scale manufacturing.
He said Hyderabad, already recognised as India’s pharmaceutical capital, was strengthening its position as a global biotechnology destination.
Hyderabad advanced medical research roadmap expands
The Minister said Hyderabad had already earned recognition as India’s pharmaceutical capital. However, the government now aims to strengthen its position as a global biotechnology destination.
He said emerging technologies such as artificial intelligence, robotics and advanced genetics would transform the biotechnology sector in the coming years.
Therefore, the State was taking strategic measures to attract investments and capitalise on future opportunities.
Sridhar Babu highlighted initiatives such as the Life Sciences Policy, One Bio Hub, Green Pharma City and Life Sciences Hub.
According to him, these projects will strengthen the global presence of the “Made in Telangana” brand in the life sciences sector.
The Minister also stressed the importance of workforce development. He said the government was focusing on world-class infrastructure as well as industry-ready talent.
Furthermore, he urged pharmaceutical and biotechnology companies to collaborate with the government on skill development programmes.
Hyderabad advanced medical research gets industrial support
Sridhar Babu described the Theranym Biologics facility as a major milestone in Telangana’s efforts to emerge as a global life sciences hub.
He reiterated the government’s commitment to supporting industrial investments and promoting innovation-driven growth.
According to the company, the facility will manufacture advanced therapeutics for cancer and other life-threatening diseases.
The company plans to export these products to several countries, including the United States.
In addition, the project is expected to generate employment for more than 1,500 people.
Health Minister Damodar Rajanarsimha, TGIIC Chairperson Nirmala Jagga Reddy and representatives of Theranym Biologics attended the inauguration programme.